The call for abstracts will cover the thematic sessions of the three tracks:
- Research
- Person-centred care
- Advocacy and policy change
Below you will find a non-extensive list of topics of interest:
- Signs and symptoms of ILD and/or IPF
- Pharmacological treatment for ILD and/or IPF
- Non-pharmacological treatment for ILD and/or IPF
- Clinical trials for ILD and/or IPF
- Insights into anti-fibrotic drugs for ILD and/or IPF
- Genotype and phenotype of ILD and/or IPF
- Self-management for ILD and/or IPF
- Multi-disciplinary approaches for ILD and/or IPF care
- Lung transplantation for ILD and/or IPF care
- Palliative care for ILD and/or IPF
- Role of pulmonary rehabilitation in IPF and/or ILD care
- Improving access to care for ILD and/or IPF patients
- Role of patient groups in the field of ILD and/or IPF
- Advocacy activities in field of ILD and/or IPF
- Policy efforts in the field of ILD and/or IPF
- Involvement of patients within the patient care pathway
- Awareness raising activities in the field of ILD and/or IPF
Abstracts that are approved will exhibit a poster during the European IPF Patient Summit 2020.